Literature DB >> 12530082

Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.

Christian Teschendorf1, Kenneth H Warrington, Dietmar W Siemann, Nicholas Muzyczka.   

Abstract

BACKGROUND: Silencing of the viral CMV immediate early enhancer promoter can be a problem in certain cell types when engineering stable cell lines.
MATERIALS AND METHODS: We compared the efficacy of the CMV promoter to the promoter of the elongation factor-1 alpha (EF-1 alpha) for the generation of stable colon carcinoma cell lines (HT-29). Green fluorescent protein (GFP) expression cassettes were delivered by recombinant adeno-associated virus (AAV) which is known for its ability to stably transduce cells. Stable cell lines were characterized in vitro by FACS and in vivo after HT-29 clones were grown as xenografts in nude mice.
RESULTS: Stable HT-29 clones with > 97% of all cells homogeneously expressing GFP were generated with the EF-1 alpha promoter. In contrast in clones carrying the CMV promoter, only up to 60% of the cells were GFP-positive with expression levels varying widely between cells. Superinfection with wild-type adenovirus induced GFP expression in more than 90% of the cells indicating that the CMV promoter was silenced. In vivo the tumors carrying the EF-1 alpha promoter were homogeneously GFP-positive, whereas the CMV promoter gave rise to a scattered pattern of GFP expression.
CONCLUSION: This study underlines the importance of the promoter for the generation of stable cell lines. In addition it demonstrates that recombinant AAV can effectively be used as a gene delivery system for this purpose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530082

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  48 in total

1.  Duck hepatitis A virus serotype 1 minigenome: a model for studying the viral 3'UTR effect on viral translation.

Authors:  Ruiying Liang; Chuanfeng Li; Hongyan Jin; Chunchun Meng; Zongyan Chen; Jie Zhu; Qiuhong Miao; Chan Ding; Guangqing Liu
Journal:  Virus Genes       Date:  2015-11-17       Impact factor: 2.332

2.  Lentiviral mediated gene delivery to the anterior chamber of rodent eyes.

Authors:  Pratap Challa; Coralia Luna; Paloma B Liton; Beth Chamblin; John Wakefield; Ram Ramabhadran; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2005-06-21       Impact factor: 2.367

3.  Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Authors:  Incilay Sinici; Maryam Zarghooni; Michael B Tropak; Don J Mahuran; H Asuman Ozkara
Journal:  Biochem Genet       Date:  2006-04-28       Impact factor: 1.890

4.  Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function.

Authors:  Xiangxu Jia; Kun Cheng; Ram I Mahato
Journal:  Mol Pharm       Date:  2007-01-26       Impact factor: 4.939

5.  A Novel Terminator Primer and Enhancer Reagents for Direct Expression of PCR-Amplified Genes in Mammalian Cells.

Authors:  Mikiko Nakamura; Ayako Suzuki; Junko Akada; Tohru Yarimizu; Ryo Iwakiri; Hisashi Hoshida; Rinji Akada
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

6.  Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.

Authors:  Rebecca L Matz; Blake Erickson; Sriram Vaidyanathan; Jolanta F Kukowska-Latallo; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

7.  Optical Tools To Study the Isoform-Specific Roles of Small GTPases in Immune Cells.

Authors:  Veronika Miskolci; Bin Wu; Yasmin Moshfegh; Dianne Cox; Louis Hodgson
Journal:  J Immunol       Date:  2016-03-07       Impact factor: 5.422

8.  Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation.

Authors:  Andreas C W Jenke; Monica F Scinteie; Isa M Stehle; Hans J Lipps
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

9.  Systematic comparison of constitutive promoters and the doxycycline-inducible promoter.

Authors:  Jane Yuxia Qin; Li Zhang; Kayla L Clift; Imge Hulur; Andy Peng Xiang; Bing-Zhong Ren; Bruce T Lahn
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

10.  Improved conditional expression systems resulting in physiological level of HNF4alpha expression confirm HNF4alpha induced apoptosis in the pancreatic beta-cell line INS-1.

Authors:  Sabine Senkel; Christoph Waldner; Gerhart U Ryffel; Heike Thomas
Journal:  BMC Res Notes       Date:  2009-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.